US Patent Family Members and Approved Drugs for Portugal Patent: 1003581
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Portugal Patent: PT1003581
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2018-01-30 | insulin detemir | Novo Nordisk Inc. | LEVEMIR |
| ⤷ Get Started Free | 2018-01-30 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| ⤷ Get Started Free | 2018-01-30 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 70/30 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
